Search

Suzetrigine

Suzetrigine is a NaV1.8 voltage-gated sodium channel blocker with analgesic properties NaV1.8 is abundantly expressed in peripheral sensory nerves to play a role in pain signal transmission, making it a desirable therapeutic target for treatment of pain. On January 30, 2025, suzetrigine was approved by the FDA as a ...